Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Clinical trial NCT05523947 · RECRUITING

Trial details

NCT number: NCT05523947
Sponsor: Yuhan Corporation
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2-Positive Solid Tumor

Start date: 2022-08-26
Primary completion: 2028-03-31
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.